Literature DB >> 7874546

Elevated cerebrospinal fluid proteins in sciatica caused by disc herniation.

J S Skouen1, J L Larsen, E Vollset, M Grønning.   

Abstract

We carried out a study of cerebrospinal fluid (CSF) proteins in 180 patients with sciatica caused by lumbar disc herniation to elucidate further the degree and mechanisms of protein elevations. The 63 controls were patients with tension headache or migraine without aura. The CSF/serum albumin ratios were higher in the patients (mean 8.84, SD 5.16) than in the controls (mean 5.60, SD 2.33). Similar differences were found for the CSF/serum IgG ratios and the CSF-total proteins. The CSF/serum albumin ratios, CSF/serum IgG ratios and the CSF-total protein concentrations were higher in men than in women among the patients. We suggest that the significant difference in ratio parameters between patients and controls indicates a leak of plasma albumin, most likely IgG, into the CSF in patients with sciatica. The leak was more pronounced in men. Also in the control group the CSF/serum albumin and CSF/serum IgG ratios were higher in men.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874546     DOI: 10.1007/bf02221449

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  20 in total

1.  Measurement of reference values for certain proteins in cerebrospinal fluid.

Authors:  A Ahonen; V V Myllylä; E Hokkanen
Journal:  Acta Neurol Scand       Date:  1978-12       Impact factor: 3.209

2.  [The Cu-Folin method for determination of the total protein content in the cerebrospinal fluid].

Authors:  H P RIEDER; R WUTHRICH
Journal:  Klin Wochenschr       Date:  1962-10-15

3.  [Elaboration of a method for the quantitative determination of proetins by laser nephelometry in the clinical routine laboratory (author's transl)].

Authors:  A Conrad; J Schürmann; F H Kreutz; A Sieber
Journal:  J Clin Chem Clin Biochem       Date:  1978-05

4.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

5.  IgG production within the central nervous system: a critical review of proposed formulae.

Authors:  A K Lefvert; H Link
Journal:  Ann Neurol       Date:  1985-01       Impact factor: 10.422

6.  Evaluation of the blood-CSF barrier by protein gradients and the humoral immune response within the central nervous system.

Authors:  K Felgenhauer; G Schliep; N Rapic
Journal:  J Neurol Sci       Date:  1976-11       Impact factor: 3.181

7.  Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification.

Authors:  T Olsson; V Kostulas; H Link
Journal:  Clin Chem       Date:  1984-07       Impact factor: 8.327

8.  Cerebrospinal fluid cholinesterases in aging and in dementia of the Alzheimer type.

Authors:  J R Atack; C May; J A Kaye; A D Kay; S I Rapoport
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

9.  Cerebrospinal fluid protein--an aid in the diagnosis of herniated discs.

Authors:  T G Tunevall
Journal:  Acta Chir Scand Suppl       Date:  1984

10.  Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients.

Authors:  H Link; V Kostulas
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

View more
  2 in total

1.  High-resolution nuclear magnetic resonance spectroscopic study of metabolites in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy.

Authors:  Hideki Nagashima; Yasuo Morio; Shunsuke Meshitsuka; Koji Yamane; Yoshiro Nanjo; Ryota Teshima
Journal:  Eur Spine J       Date:  2010-05-20       Impact factor: 3.134

2.  Tumor necrosis factor-alpha, interleukin-1beta, and interleukin-6 in the cerebrospinal fluid of patients with cervical myelopathy and lumbar radiculopathy.

Authors:  Hideki Nagashima; Yasuo Morio; Koji Yamane; Yoshiro Nanjo; Ryota Teshima
Journal:  Eur Spine J       Date:  2009-06-19       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.